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Abstract Nitration of tyrosine residues in proteins has been
observed in many in£ammatory tissues of arthritis, ulcerative
colitis, septic shock and ischemia-reperfusion injury. Although
several studies have been carried out, it is still unclear what type
of protein is nitrated and whether tyrosine nitration interferes
with protein function. Peroxisome proliferator-activated recep-
tor gamma (PPARQ) is a nuclear receptor whose activation is
linked to several physiological pathways including regulation of
insulin sensitivity and control of in£ammation. PPARQ possesses
several tyrosine residues, which might be potential targets for
nitration by peroxynitrite during in£ammatory responses. Here
we have investigated whether PPARQ is nitrated in macrophage-
like RAW 264 cells and the e¡ect of nitration on the trans-
location of PPARQ into the nucleus. Western blot analysis
showed that tumor necrosis factor-K, lipopolysaccharide or per-
oxynitrite treatment signi¢cantly increases the nitration of
PPARQ. Cell fractionation analysis and immuno£uorescence
coupled with confocal laser microscopy revealed that nitration
of PPARQ inhibits its ligand-dependent translocation from the
cytosol into the nucleus. Together, these results indicate that
nitration of PPARQ during in£ammation may be involved in a
reduction in the control of in£ammatory responses and also in
the development of resistance to PPARQ ligand-based therapies
against in£ammation. , 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Nitration of tyrosine residues in proteins is observed in
many diseases such as arthritis, nephritis, ulcerative colitis,
ischemia-reperfusion injury, septic shock, and neuronal disor-
ders [1^6]. Most reports have indicated that increased forma-
tion of nitrotyrosine is a marker of in£ammation in tissues,
because nitrotyrosine is formed through the reaction of a ty-
rosine residue with peroxynitrite that is generated from super-
oxide and nitric oxide (NO) radicals [7,8]. Although the
pathological or physiological roles of nitrotyrosine are still
unknown, several studies have reported that nitrotyrosine for-
mation may alter the function of proteins in signal transduc-
tion pathways [9^12].
Peroxisome proliferator-activated receptor gamma (PPARQ)
is a member of the nuclear receptor superfamily of ligand-
activated transcriptional factors and plays a key role in adi-
pocyte di¡erentiation and insulin sensitivity [13^15]. Synthetic
ligands of PPARQ, such as troglitazone, pioglitazone and ro-
siglitazone (Rosi), are used as oral anti-hyperglycemic agents
in therapy of non-insulin-dependent diabetes mellitus. Recent
studies have shown that, in addition to its classical role, PPARQ
may also be involved in the control of in£ammation, in par-
ticular in modulating the production of in£ammatory media-
tors [16,17]. We previously reported that the endogenous
PPARQ pathway acts against in£ammation in the gastrointes-
tinal tract in animal models of in£ammatory bowel disease,
such as dextran sodium sulfate- and ischemia-induced colitis
[18^20]. Therefore, the endogenous PPARQ pathway is con-
sidered a preventive system for excessive in£ammation, and
thus dysfunction or suppression of PPARQ may cause aggra-
vation of chronic or recurrent in£ammation.
Here we have focused on the nitration of PPARQ proteins
in the macrophage-like cell line RAW 264 and investigated
whether PPARQ functions are a¡ected by nitration. Macro-
phage cells are considered key players in in£ammation and
highly express PPARQ proteins, therefore, it is important to
investigate the e¡ect of alterations in the function of the
PPARQ pathway in these cells. In this study, nitration of
PPARQ in RAW 264 cells was induced by stimulation with
peroxynitrite, lipopolysaccharide (LPS) or tumor necrosis fac-
tor-K (TNF-K). We report that the stimulation of RAW 264
cells caused strong nitration of PPARQ, which in turn inhib-
ited its ligand-dependent translocation from the cytosol into
the nucleus.
2. Materials and methods
2.1. Reagents and antibodies
The PPARQ-speci¢c ligand, Rosi, was a kind gift from Glaxo
SmithKline (Tokyo, Japan). Anti-PPARQ polyclonal and monoclonal
antibodies were purchased from Santa Cruz (Santa Cruz, CA, USA).
Anti-nitrotyrosine monoclonal antibody was purchased from Zymed
(Zymed Laboratories Inc., CA, USA). LPS and TNF-K were pur-
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chased from Sigma (Tokyo, Japan). Peroxynitrite solution was pur-
chased from Dojindo (Kumamoto, Japan). All other chemicals were
reagent grade.
2.2. Cell culture and ligand treatment
RAW 264 cells, a murine peritoneal macrophage-like cell line, were
purchased from RIKEN GenBank (Tokyo, Japan). The cells were
cultured to con£uence in Dulbecco’s modi¢ed Eagle’s medium (Sigma,
Tokyo, Japan) supplemented with penicillin (5 U/ml), streptomycin
(5 Wg/ml) and amphotericin B (250 ng/ml) in 10 cm dishes at 37‡C
under 5% CO2. RAW 264 cells were stimulated by TNF-K (50 ng/ml),
LPS (10 Wg/ml) or vehicle for 18 h, incubated with or without PPARQ
ligand (Rosi, 30 WM) for 3 h, and then harvested. For peroxynitrite,
stimulation was performed for 40 min, followed by incubation with
PPARQ ligand as described above.
2.3. Preparation of cell extracts and fractionation
Cells were homogenized in lysis bu¡er (20 mM Tris^HCl, 150 mM
NaCl, 4 mM EGTA, 1% Triton X-100) containing a cocktail of pro-
tease inhibitors (Sigma, Tokyo, Japan). Cell extracts were prepared by
a centrifugation at 16 000Ug, and used for sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE). Immunoprecipita-
tion was carried out overnight by rotation with anti-PPARQ polyclon-
al antibody crosslinked to Protein G-Sepharose beads (Amersham
Pharmacia Biotech Japan, Tokyo, Japan) [21]. Cytosol and nuclear
fractions were prepared using NE-PER Nuclear and cytoplasmic ex-
traction reagents (Pierce, Rockford, IL, USA) according to the man-
ufacturer’s instructions.
2.4. Western blot analysis
Samples (each containing 20 Wg protein) were resolved by SDS^
PAGE and transferred onto a polyvinylidene di£uoride membrane.
Anti-nitrotyrosine antibody, anti-PPARQ monoclonal or polyclonal
antibody were applied overnight at 4‡C. Immunoreactivity was de-
tected with an ECL-plus kit (Amersham, London, UK).
2.5. Confocal microscopy
RAW 264 cells were cultured on a Lab-Tek II chamber slide (Nalge
Nunc International, Naperville, IL, USA). Four variations of stimu-
lation and ligand treatment were performed as follows: no stimulation
plus vehicle (no ligand), no stimulation plus ligand (Rosi, 30 WM),
LPS stimulation plus Rosi and TNF-K stimulation plus Rosi. Stimu-
lation with TNF-K or LPS was carried out for 18 h, followed by
treatment with Rosi (30 WM) for 3 h. The cells were then ¢xed with
4% paraformaldehyde in phosphate-bu¡ered saline (PBS) for 10 min,
permeabilized in PBS containing 0.1% Triton X-100 for 30 min and
rinsed with PBS. The ¢xed cells were incubated with anti-PPARQ
rabbit polyclonal antibody (1:1000) for 16 h at 4‡C and then with
Alexa Fluor 488 goat anti-rabbit IgG antibody (Molecular Probes,
Eugene, OR, USA) for 1 h. Nuclear staining was performed by in-
cubation with SYTOX Orange (Molecular Probes, Eugene, OR,
USA). A confocal laser-scanning microscope (MRC1024, Bio-Rad,
Tokyo, Japan) was used to visualize the localization of PPARQ.
3. Results
3.1. PPARQ proteins are strongly nitrated by peroxynitrite
or LPS
We previously observed that peroxynitrite treatment (500
WM, 40 min) in RAW 264 cells induced the nitration of tyro-
sine residues in several proteins, including proteins with mo-
lecular weights of 6 37, 50, 70, 100^110 and 150^180 kDa
[22]. Although these proteins have not been identi¢ed, we
focused on the 50-kDa protein, which was strongly nitrated
by peroxynitrite (Fig. 1, upper panel). In particular, the mo-
lecular weight of PPARQ is 50 kDa and we therefore inves-
tigated whether PPARQ is the 50-kDa nitrated protein.
We immunoprecipitated the nitrated proteins using anti-
PPARQ polyclonal antibody and analyzed them by Western
blot using anti-nitrotyrosine monoclonal antibody. Fig. 2
shows the nitration of immunoprecipitated and non-immuno-
precipitated proteins from peroxynitrite-treated or LPS-stimu-
lated RAW 264 cells. Although peroxynitrite or LPS caused
the nitration of several proteins in non-immunoprecipitated
samples (no IP in Fig. 2A), the proteins immunoprecipitated
by anti-PPARQ antibody were strongly nitrated (IP in Fig.
2A). We examined a competitive blocking of nitrated signals
to anti-nitrotyrosine antibody by an excessive amount of
3-nitrotyrosine to verify the immunostaining of nitrated pro-
teins. As shown in Fig. 2B, the nitrated signals to anti-nitro-
tyrosine antibody were diminished by the presence of 3-nitro-
tyrosine. These results indicate that those immunoreactive
proteins to anti-nitrotyrosine antibody are nitrated proteins.
We also con¢rmed that the protein amount of PPARQ was
not altered by the treatment (Fig. 1, lower panel). These re-
sults clearly indicate that PPARQ proteins are strongly ni-
trated after stimulation with LPS or peroxynitrite in RAW
264 cells.
Fig. 1. Nitration of PPARQ in RAW 264 cells by peroxynitrite. Western blot analysis using anti-nitrotyrosine (upper panel) or anti-PPARQ
(lower panel) antibody was applied to cell extracts from RAW 264 cells treated with peroxynitrite (ONOO3, 500 WM, 40 min). Although sev-
eral proteins were nitrated, 50-kDa PPARQ protein was strongly nitrated (arrow in upper panel). Treatment with peroxynitrite did not alter the
protein amounts of PPARQ protein (lower panel).
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3.2. Nitration of PPARQ inhibits ligand-induced translocation
into the nucleus
To investigate whether nitration of PPARQ may alter the
function as a receptor and transcriptional regulator, we exam-
ined the ligand-dependent translocation of PPARQ into the
nucleus in RAW 264 cells under the normal and nitrated
conditions. RAW 264 cells were stimulated with or without
LPS or TNF-K, and then incubated with PPARQ ligand (Rosi)
or vehicle. Subsequently, cytosol and nuclear fractions were
prepared and applied to Western blot analysis using anti-
PPARQ antibody. In non-stimulated RAW 264 cells, PPARQ
was mainly observed in the cytosol fraction. After treatment
with the ligand (Rosi, 30 WM), however, PPARQ was observed
in the nuclear fraction (Fig. 3). By contrast, in RAW 264 cells
Fig. 2. Nitration of proteins immunoprecipitated by anti-PPARQ antibody from peroxynitrite (ONOO3)- or LPS-stimulated RAW 264 cells.
A: Immunoprecipitated (IP) or non-immunoprecipitated (no IP) samples were applied to SDS^PAGE and then analyzed for immunoreactivity
to anti-nitrotyrosine antibody. Arrows indicate PPARQ. B: Competitive blocking of nitrotyrosine signals by 3-nitrotyrosine. Immunoreaction to
anti-nitrotyrosine antibody was performed with the presence of 3-nitrotyrosine (10 mM). MM indicates molecular markers.
Fig. 3. Ligand-dependent translocation of PPARQ from the cytosol into the nucleus. RAW 264 cells were treated with (LPS or TNF-K) or with-
out (3) stimulant for 18 h, and then incubated with the ligand (Rosi, 30 WM) for 3 h. Cytosol and nuclear fractions were analyzed by anti-
PPARQ antibody. Std indicates control PPARQ protein.
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stimulated with LPS or TNF-K, nitrated PPARQ remained in
the cytosol after treatment with PPARQ ligand (Fig. 3).
To con¢rm these results, we examined the ligand-dependent
translocation of PPARQ into the nucleus using confocal laser
microscopy. As shown in Fig. 4, the localization of PPARQ in
RAW 264 cells was visualized by immuno£uorescence using
anti-PPARQ polyclonal antibody. Although in non-stimulated
RAW 264 cells PPARQ was translocated from the cytosol into
Fig. 4. Visualization of ligand-dependent translocation of PPARQ by confocal laser microscopy. RAW 264 cells were treated with (LPS or
TNF-K) or without (3) stimulant and PPARQ ligand as described in the legend of Fig. 3. The ¢xed cells were treated with anti-PPARQ poly-
clonal antibody, followed by Alexa Fluor 488 goat anti-rabbit IgG antibody. Nuclear staining was performed by SYTOX Orange. Green color
represents PPARQ (upper panels); red color represents nucleus (middle panels). Merged pictures of green and red colors are shown in the lower
panels.
Fig. 5. Cell survival rate under the experimental conditions. Cells were stimulated by LPS, TNF-K, LPS plus TNF-K or vehicle for 0^6 h, and
trypan blue dye excretion was measured. The percentage of surviving cells compared with that of vehicle-treated control cells is shown from
three independent experiments.
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the nucleus by treatment with Rosi, this ligand-dependent
translocation was inhibited in RAW 264 cells stimulated
with LPS or TNF-K. These results indicate that nitration of
PPARQ may inhibit its function as a receptor and transcrip-
tional regulator.
To rule out the possibility that loss of PPARQ translocation
is caused by a loss of cell viability, we measured cell survival
and proliferation rates in our experimental conditions by try-
pan blue excretion and MTT assay. As shown in Fig. 5, try-
pan blue excretion showed that there is no signi¢cant di¡er-
ence between control cells and treated cells, although cells
treated with LPS plus TNF-K showed a slightly increased
cell survival rate. Similar results were obtained with the
MTT assay (data not shown). These results clearly rule out
the possibility that loss of PPARQ translocation was caused by
loss of cell viability.
4. Discussion
It is well known that superoxide and NO radicals react
rapidly to form peroxynitrite, which then attacks tyrosine res-
idues in proteins to form nitrotyrosine [1,7]. Although many
studies have reported that increased formation of nitrotyro-
sine is a biomarker for in£ammation [2^5], few studies have
identi¢ed functional alterations in the nitrated proteins. Re-
cently, nitration has been reported to cause alterations in the
tyrosine kinase pathway [10^12]. However, no studies have
examined the e¡ects of the nitration of nuclear receptors on
their functions in in£ammatory cells.
In the present study, we observed the selective nitration of
PPARQ in stimulated macrophage-like RAW 264 cells.
Although several proteins in RAW 264 cells were nitrated
by LPS, TNF-K or peroxynitrite, PPARQ was strongly ni-
trated. This is the ¢rst report to identify the speci¢c nitration
of PPARQ. PPARQ proteins have many tyrosine residues [23],
which may be potential targets for nitration by peroxynitrite
or other radicals during in£ammatory responses.
In addition, we investigated the functional e¡ect of the
nitration of PPARQ in RAW 264 cells. PPARQ is the member
of the nuclear receptor superfamily and plays a key role in
adipocyte di¡erentiation, insulin sensitivity and anti-in£am-
mation [13^20]. Activation of the PPARQ pathway starts in
the cytosol by the binding of speci¢c ligands to PPARQ, which
subsequently translocates into the nucleus; we therefore
thought ligand-dependent translocation from the cytosol
into the nucleus might be a¡ected by tyrosine nitration. In-
deed, as clearly shown in Figs. 3 and 4, ligand-dependent
translocation was not observed when PPARQ had been pre-
viously nitrated by LPS, TNF-K or peroxynitrite. Moreover,
we showed that the loss of PPARQ translocation was not due
to cell death or loss of viability.
Because the endogenous PPARQ pathway is considered a
preventive system to avoid excessive in£ammatory responses,
the dysfunction or suppression of the PPARQ pathway may
cause aggravation of chronic or recurrent in£ammation. Our
results therefore indicate that nitration of PPARQ during in-
£ammation may participate in sustained in£ammation and
may also explain the resistance to PPARQ ligand-based thera-
pies against in£ammation. Further investigations are required
to clarify mechanistic details.
In conclusion, PPARQ was selectively nitrated following in-
£ammatory stimulation in RAW 264 cells, which subsequently
inhibited its ligand-dependent translocation into the nucleus.
These results indicate that nitration of PPARQ during in£am-
mation may result in increased in£ammation, owing to a re-
duction in the anti-in£ammatory e¡ect of the PPARQ path-
way.
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